Literature DB >> 7030470

An enzyme immunoassay for the detection of human tumor nucleolar antigens.

D E Kelsey, R K Busch, H Busch.   

Abstract

An enzyme immunoassay (EIA) was developed in which nuclear extracts were bound to the wells of polystyrene microtiter plates. The presence of various antigens in the extracts could be detected using antiserum raised against HeLa cell nucleoli. Normal human cell extracts, coupled to Sepharose as a solid phase absorbent, were used to remove antibodies directed against antigens present in normal cells, The resulting purified antibodies produced a linear EIA absorbance in the range of 100-500 ng tumor extract, but little EIA absorbance with nuclear extracts from human placenta and liver.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7030470     DOI: 10.1016/0304-3835(81)90171-3

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  5 in total

1.  Immunohistochemical and biochemical characterization of antisera raised to human tumor nucleoli.

Authors:  R S Greenfield; M O Lamon; L J Olech; J A Grattan
Journal:  J Cancer Res Clin Oncol       Date:  1989       Impact factor: 4.553

2.  Microinjection of anti-topoisomerase I immunoglobulin G into nuclei of Chironomus tentans salivary gland cells leads to blockage of transcription elongation.

Authors:  E Egyházi; E Durban
Journal:  Mol Cell Biol       Date:  1987-12       Impact factor: 4.272

3.  Further characterization of an MSP-1-derived transcription particle (transcripton) using monoclonal and polyclonal antibodies.

Authors:  N L Rosenberg
Journal:  Mol Cell Biochem       Date:  1987-05       Impact factor: 3.396

4.  Identification and purification of Namalwa nuclear RNP antigen 52/5.3.

Authors:  K Takahashi; P K Chan; R K Busch; H Busch
Journal:  J Cancer Res Clin Oncol       Date:  1983       Impact factor: 4.553

Review 5.  Purification of p53/55 kinase from nuclear ribonucleoproteins of Namalwa cells.

Authors:  D A Graham; J K Deb; H Busch
Journal:  Mol Cell Biochem       Date:  1984-08       Impact factor: 3.396

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.